Global (United States, European Union and China) Oral Contraceptive Market Research Report 2019-2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Oral Contraceptive Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Combination
- 1.3.3 Progestin Only
- 1.3.4 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Oral Contraceptive Market Share by Application (2019-2025)
- 1.4.2 Male
- 1.4.3 Female
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Oral Contraceptive Market Size
- 2.1.1 Global Oral Contraceptive Revenue 2014-2025
- 2.1.2 Global Oral Contraceptive Sales 2014-2025
- 2.2 Oral Contraceptive Growth Rate by Regions
- 2.2.1 Global Oral Contraceptive Sales by Regions 2014-2019
- 2.2.2 Global Oral Contraceptive Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Oral Contraceptive Sales by Manufacturers
- 3.1.1 Oral Contraceptive Sales by Manufacturers 2014-2019
- 3.1.2 Oral Contraceptive Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Oral Contraceptive Revenue by Manufacturers (2014-2019)
- 3.2.2 Oral Contraceptive Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Oral Contraceptive Market Concentration Ratio (CR5 and HHI)
- 3.3 Oral Contraceptive Price by Manufacturers
- 3.4 Key Manufacturers Oral Contraceptive Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Oral Contraceptive Market
- 3.6 Key Manufacturers Oral Contraceptive Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Combination Sales and Revenue (2014-2019)
- 4.1.2 Progestin Only Sales and Revenue (2014-2019)
- 4.1.3 Others Sales and Revenue (2014-2019)
- 4.2 Global Oral Contraceptive Sales Market Share by Type
- 4.3 Global Oral Contraceptive Revenue Market Share by Type
- 4.4 Oral Contraceptive Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Oral Contraceptive Sales by Application
6 United States
- 6.1 United States Oral Contraceptive Breakdown Data by Company
- 6.2 United States Oral Contraceptive Breakdown Data by Type
- 6.3 United States Oral Contraceptive Breakdown Data by Application
7 European Union
- 7.1 European Union Oral Contraceptive Breakdown Data by Company
- 7.2 European Union Oral Contraceptive Breakdown Data by Type
- 7.3 European Union Oral Contraceptive Breakdown Data by Application
8 China
- 8.1 China Oral Contraceptive Breakdown Data by Company
- 8.2 China Oral Contraceptive Breakdown Data by Type
- 8.3 China Oral Contraceptive Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Oral Contraceptive Breakdown Data by Company
- 9.2 Rest of World Oral Contraceptive Breakdown Data by Type
- 9.3 Rest of World Oral Contraceptive Breakdown Data by Application
- 9.4 Rest of World Oral Contraceptive Breakdown Data by Countries
- 9.4.1 Rest of World Oral Contraceptive Sales by Countries
- 9.4.2 Rest of World Oral Contraceptive Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pfizer, Inc.
- 10.1.1 Pfizer, Inc. Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Oral Contraceptive
- 10.1.4 Oral Contraceptive Product Introduction
- 10.1.5 Pfizer, Inc. Recent Development
- 10.2 Bayer AG
- 10.2.1 Bayer AG Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Oral Contraceptive
- 10.2.4 Oral Contraceptive Product Introduction
- 10.2.5 Bayer AG Recent Development
- 10.3 Merck & Co., Inc.
- 10.3.1 Merck & Co., Inc. Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Oral Contraceptive
- 10.3.4 Oral Contraceptive Product Introduction
- 10.3.5 Merck & Co., Inc. Recent Development
- 10.4 Janssen Global Services, LLC
- 10.4.1 Janssen Global Services, LLC Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Oral Contraceptive
- 10.4.4 Oral Contraceptive Product Introduction
- 10.4.5 Janssen Global Services, LLC Recent Development
- 10.5 Mankind Pharma Ltd.
- 10.5.1 Mankind Pharma Ltd. Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Oral Contraceptive
- 10.5.4 Oral Contraceptive Product Introduction
- 10.5.5 Mankind Pharma Ltd. Recent Development
- 10.6 Teva Pharmaceutical Industries Ltd
- 10.6.1 Teva Pharmaceutical Industries Ltd Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Oral Contraceptive
- 10.6.4 Oral Contraceptive Product Introduction
- 10.6.5 Teva Pharmaceutical Industries Ltd Recent Development
- 10.7 Allergan, plc (Actavis)
- 10.7.1 Allergan, plc (Actavis) Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Oral Contraceptive
- 10.7.4 Oral Contraceptive Product Introduction
- 10.7.5 Allergan, plc (Actavis) Recent Development
- 10.8 Piramal Enterprises Ltd.
- 10.8.1 Piramal Enterprises Ltd. Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Oral Contraceptive
- 10.8.4 Oral Contraceptive Product Introduction
- 10.8.5 Piramal Enterprises Ltd. Recent Development
- 10.9 Beijing Zizhu Pharm
- 10.9.1 Beijing Zizhu Pharm Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Oral Contraceptive
- 10.9.4 Oral Contraceptive Product Introduction
- 10.9.5 Beijing Zizhu Pharm Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Oral Contraceptive Sales Channels
- 11.2.2 Oral Contraceptive Distributors
- 11.3 Oral Contraceptive Customers
12 Market Forecast
- 12.1 Global Oral Contraceptive Sales and Revenue Forecast 2019-2025
- 12.2 Global Oral Contraceptive Sales Forecast by Type
- 12.3 Global Oral Contraceptive Sales Forecast by Application
- 12.4 Oral Contraceptive Forecast by Regions
- 12.4.1 Global Oral Contraceptive Sales Forecast by Regions 2019-2025
- 12.4.2 Global Oral Contraceptive Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
In 2019, the market size of Oral Contraceptive is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Oral Contraceptive.
This report studies the global market size of Oral Contraceptive, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Oral Contraceptive sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer, Inc.
Bayer AG
Merck & Co., Inc.
Janssen Global Services, LLC
Mankind Pharma Ltd.
Teva Pharmaceutical Industries Ltd
Allergan, plc (Actavis)
Piramal Enterprises Ltd.
Beijing Zizhu Pharm
Market Segment by Product Type
Combination
Progestin Only
Others
Market Segment by Application
Male
Female
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Oral Contraceptive status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Oral Contraceptive manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Oral Contraceptive are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025